标题
MiR-200c and HuR in ovarian cancer
作者
关键词
Ovarian cancer, miR-200c, Class III beta-tubulin, HuR, Predictive biomarkers
出版物
BMC CANCER
Volume 13, Issue 1, Pages -
出版商
Springer Nature
发表日期
2013-02-09
DOI
10.1186/1471-2407-13-72
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Restoration of miR-200c to Ovarian Cancer Reduces Tumor Burden and Increases Sensitivity to Paclitaxel
- (2012) D. M. Cittelly et al. MOLECULAR CANCER THERAPEUTICS
- Class III β-tubulin and the cytoskeletal gateway for drug resistance in ovarian cancer
- (2011) Marta De Donato et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
- (2011) Sergio Marchini et al. LANCET ONCOLOGY
- Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA Stability
- (2011) Neelanjan Mukherjee et al. MOLECULAR CELL
- HuR Regulates -Tubulin Isotype Expression in Ovarian Cancer
- (2010) G. Raspaglio et al. CANCER RESEARCH
- The ZEB/miR-200 feedback loop—a motor of cellular plasticity in development and cancer?
- (2010) Simone Brabletz et al. EMBO REPORTS
- The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
- (2010) S. Leskela et al. ENDOCRINE-RELATED CANCER
- MicroRNAs in ovarian cancer biology and therapy resistance
- (2010) Marijn T.M. van Jaarsveld et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Posttranscriptional regulation of cancer traits by HuR
- (2010) Kotb Abdelmohsen et al. Wiley Interdisciplinary Reviews-RNA
- A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer
- (2009) Xiaoxia Hu et al. GYNECOLOGIC ONCOLOGY
- Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
- (2009) Ram Eitan et al. GYNECOLOGIC ONCOLOGY
- Integrated genomics of chemotherapy resistant ovarian cancer: A role for extracellular matrix, TGFbeta and regulating microRNAs
- (2009) Jozien Helleman et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Role of hypoxia in the hallmarks of human cancer
- (2009) Kai Ruan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
- (2009) D. R. Cochrane et al. MOLECULAR CANCER THERAPEUTICS
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
- (2009) Dawn R. Cochrane et al. Journal of Oncology
- Molecular Mechanisms of Patupilone Resistance
- (2008) S. Mozzetti et al. CANCER RESEARCH
- MicroRNA Expression Profiles in Serous Ovarian Carcinoma
- (2008) E. J. Nam et al. CLINICAL CANCER RESEARCH
- Hypoxia induces class III beta-tubulin gene expression by HIF-1α binding to its 3' flanking region
- (2007) Giuseppina Raspaglio et al. GENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started